William P. Forbes - 16 Nov 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
EVP, Chief Development Officer
Signature
/s/ Lisa Peraza Attorney-in-fact for William Forbes
Issuer symbol
HRTX
Transactions as of
16 Nov 2023
Net transactions value
+$46,995
Form type
4
Filing time
20 Nov 2023, 10:07:28 UTC
Previous filing
12 Jun 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Purchase $46,995 +50,000 +1250% $0.9399 54,000 16 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of purchase prices paid was $0.9348 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.